KARYOPHARM
Live / Registered — Registered (as of 18 Jun 2024)
What this means for you
Registered since 18 Jun 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 18 Jun 2030: the §8 declaration of use).
Record
- Serial number
- 90755312
- Registration number
- 7422474
- Mark type
- Word mark
- Filed
- 04 Jun 2021
- Published for opposition
- 11 Apr 2023
- Registered
- 18 Jun 2024
- Next maintenance filing
- §8 declaration of use, due by 18 Jun 2030 (grace period to 18 Dec 2030)
- Attorney of record
- Nicole Kinsley
Goods and services
- Class 005 — Pharmaceuticals: pharmaceuticals for treatment of life threatening diseases; pharmaceuticals for treatment of cancer
Owner
- Karyopharm Therapeutics Inc., Newton, MA
- Karyopharm Therapeutics Inc., Newton, MA
- Karyopharm Therapeutics Inc., Newton, MA
Prior registrations
Prosecution history
- 08 Dec 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 08 Dec 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 16 Oct 2024 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 18 Jun 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Jun 2024 — REGISTERED-PRINCIPAL REGISTER
- 14 May 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 14 May 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 May 2024 — EXAMINER'S AMENDMENT ENTERED
- 12 May 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 12 May 2024 — EXAMINERS AMENDMENT E-MAILED
- 12 May 2024 — SU-EXAMINER'S AMENDMENT WRITTEN
- 15 Jan 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 15 Jan 2024 — NON-FINAL ACTION E-MAILED
- 15 Jan 2024 — SU - NON-FINAL ACTION - WRITTEN
- 06 Jan 2024 — STATEMENT OF USE PROCESSING COMPLETE